請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33484完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳水田(Shui-Tein Chen) | |
| dc.contributor.author | Hsien-Yu Tsai | en |
| dc.contributor.author | 蔡顯裕 | zh_TW |
| dc.date.accessioned | 2021-06-13T04:43:07Z | - |
| dc.date.available | 2014-07-29 | |
| dc.date.copyright | 2011-07-29 | |
| dc.date.issued | 2011 | |
| dc.date.submitted | 2011-07-27 | |
| dc.identifier.citation | 1. Levin, P. B. B., ed. (2008) World cancer report 2008, International Agency for Research on Cancer, World Health Organiztion, Lyon.
2. Zochbauer-Muller, S., Gazdar, A. F., and Minna, J. D. (2002) Molecular pathogenesis of lung cancer. Annu Rev Physiol 64, 681-708. 3. CEPD, ed. (2009) Taiwan Statistical Data Book, First edition Ed., Council for Economic Planning and Development, R.O.C. (Taiwan). 4. Travis, W. D., Travis, L. B., and Devesa, S. S. (1995) Lung cancer. Cancer 75, 191-202. 5. Bharti, A., Ma, P. C., and Salgia, R. (2007) Biomarker discovery in lung cancer--promises and challenges of clinical proteomics. Mass Spectrom Rev 26, 451-466. 6. Schneider, J. (2006) Tumor markers in detection of lung cancer. Adv Clin Chem 42, 1-41. 7. Patz, E. F., Jr., Campa, M. J., Gottlin, E. B., Kusmartseva, I., Guan, X. R., and Herndon, J. E., 2nd (2007) Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 25, 5578-5583. 8. Aberle, D. R., Berg, C. D., Black, W. C., Church, T. R., Fagerstrom, R. M., Galen, B., Gareen, I. F., Gatsonis, C., Goldin, J., Gohagan, J. K., Hillman, B., Jaffe, C., Kramer, B. S., Lynch, D., Marcus, P. M., Schnall, M., Sullivan, D. C., Sullivan, D., and Zylak, C. J. (2011) The National Lung Screening Trial: overview and study design. Radiology 258, 243-253. 9. Kurosky, A., Barnett, D. R., Lee, T. H., Touchstone, B., Hay, R. E., Arnott, M. S., Bowman, B. H., and Fitch, W. M. (1980) Covalent structure of human haptoglobin: a serine protease homolog. Proc Natl Acad Sci U S A 77, 3388-3392. 10. McGill, J. R., Yang, F., Baldwin, W. D., Brune, J. L., Barnett, D. R., Bowman, B. H., and Moore, C. M. (1984) Localization of the haptoglobin alpha and beta genes (HPA and HPB) to human chromosome 16q22 by in situ hybridization. Cytogenet Cell Genet 38, 155-157. 11. Bensi, G., Raugei, G., Klefenz, H., and Cortese, R. (1985) Structure and expression of the human haptoglobin locus. EMBO J 4, 119-126. 12. Tubbs, K. A., Kiernan, U. A., Niederkofler, E. E., Nedelkov, D., Bieber, A. L., and Nelson, R. W. (2005) High-throughput MS-based protein phenotyping: application to haptoglobin. Proteomics 5, 5002-5007. 13. Carter, K., and Worwood, M. (2007) Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol 29, 92-110. 14. Na, N., Delanghe, J. R., Taes, Y. E., Torck, M., Baeyens, W. R., and Ouyang, J. (2006) Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese. Clin Chim Acta 365, 319-324. 15. Blackwell, R. Q., Lin, T. Y., and Shiao, D. D. (1962) Distribution of haptoglobins among Chinese in Taiwan. Nature 193, 284-285. 16. Gast, M. C., van Tinteren, H., Bontenbal, M., van Hoesel, R. Q., Nooij, M. A., Rodenhuis, S., Span, P. N., Tjan-Heijnen, V. C., de Vries, E. G., Harris, N., Twisk, J. W., Schellens, J. H., and Beijnen, J. H. (2008) Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients. BMC Cancer 8, 389. 17. Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H. J., Law, S. K., and Moestrup, S. K. (2001) Identification of the haemoglobin scavenger receptor. Nature 409, 198-201. 18. Nielsen, M. J., and Moestrup, S. K. (2009) Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 114, 764-771. 19. Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T., Yamanaka, K., Moriwaki, K., Murata, K., Ohigashi, H., Yokoyama, S., Eguchi, H., Ishikawa, O., Ito, T., Kato, M., Kasahara, A., Kawano, S., Gu, J., Taniguchi, N., and Miyoshi, E. (2006) Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer 118, 2803-2808. 20. Ang, I. L., Poon, T. C., Lai, P. B., Chan, A. T., Ngai, S. M., Hui, A. Y., Johnson, P. J., and Sung, J. J. (2006) Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. J Proteome Res 5, 2691-2700. 21. Fujimura, T., Shinohara, Y., Tissot, B., Pang, P. C., Kurogochi, M., Saito, S., Arai, Y., Sadilek, M., Murayama, K., Dell, A., Nishimura, S., and Hakomori, S. I. (2008) Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects. Int J Cancer 122, 39-49. 22. Hoagland, L. F. t., Campa, M. J., Gottlin, E. B., Herndon, J. E., 2nd, and Patz, E. F., Jr. (2007) Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer. Cancer 110, 2260-2268. 23. Lau, K. S., and Dennis, J. W. (2008) N-Glycans in cancer progression. Glycobiology 18, 750-760. 24. Fuster, M. M., and Esko, J. D. (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5, 526-542. 25. Kirmiz, C., Li, B., An, H. J., Clowers, B. H., Chew, H. K., Lam, K. S., Ferrige, A., Alecio, R., Borowsky, A. D., Sulaimon, S., Lebrilla, C. B., and Miyamoto, S. (2007) A serum glycomics approach to breast cancer biomarkers. Mol Cell Proteomics 6, 43-55. 26. Arnold, J. N., Saldova, R., Hamid, U. M., and Rudd, P. M. (2008) Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 8, 3284-3293. 27. Kannagi, R., Izawa, M., Koike, T., Miyazaki, K., and Kimura, N. (2004) Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Science 95, 377-384. 28. Hakomori, S. (2002) Glycosylation defining cancer malignancy: New wine in an old bottle. Proceedings of the National Academy of Sciences of the United States of America 99, 10231-10233. 29. Miyagi, T., Wada, T., Yamaguchi, K., Shiozaki, K., Sato, I., Kakugawa, Y., Yamanami, H., and Fujiya, T. (2008) Human sialidase as a cancer marker. Proteomics 8, 3303-3311. 30. Gorelik, E., Galili, U., and Raz, A. (2001) On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer and Metastasis Reviews 20, 245-277. 31. An, H. J., Kronewitter, S. R., de Leoz, M. L., and Lebrilla, C. B. (2009) Glycomics and disease markers. Curr Opin Chem Biol. 32. Ohyabu, N., Hinou, H., Matsushita, T., Izumi, R., Shimizu, H., Kawamoto, K., Numata, Y., Togame, H., Takemoto, H., Kondo, H., and Nishimura, S. I. (2009) An Essential Epitope of Anti-MUC1 Monoclonal Antibody KL-6 Revealed by Focused Glycopeptide Library. J Am Chem Soc. 33. Leth-Larsen, R., Lund, R. R., and Ditzel, H. J. (2010) Plasma membrane proteomics and its application in clinical cancer biomarker discovery. Mol Cell Proteomics 9, 1369-1382. 34. Comunale, M. A., Wang, M., Hafner, J., Krakover, J., Rodemich, L., Kopenhaver, B., Long, R. E., Junaidi, O., Bisceglie, A. M., Block, T. M., and Mehta, A. S. (2009) Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J Proteome Res 8, 595-602. 35. Misonou, Y., Shida, K., Korekane, H., Seki, Y., Noura, S., Ohue, M., and Miyamoto, Y. (2009) Comprehensive Clinico-Glycomic Study of 16 Colorectal Cancer Specimens: Elucidation of Aberrant Glycosylation and Its Mechanistic Causes in Colorectal Cancer Cells. J Proteome Res, 2290-2305. 36. Miyoshi, E., Moriwaki, K., and Nakagawa, T. (2008) Biological function of fucosylation in cancer biology. J Biochem 143, 725-729. 37. Miyoshi, E., and Nakano, M. (2008) Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures. Proteomics 8, 3257-3262. 38. Abd Hamid, U. M., Royle, L., Saldova, R., Radcliffe, C. M., Harvey, D. J., Storr, S. J., Pardo, M., Antrobus, R., Chapman, C. J., Zitzmann, N., Robertson, J. F., Dwek, R. A., and Rudd, P. M. (2008) A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 18, 1105-1118. 39. Saldova, R., Royle, L., Radcliffe, C. M., Abd Hamid, U. M., Evans, R., Arnold, J. N., Banks, R. E., Hutson, R., Harvey, D. J., Antrobus, R., Petrescu, S. M., Dwek, R. A., and Rudd, P. M. (2007) Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 17, 1344-1356. 40. Nakano, M., Nakagawa, T., Ito, T., Kitada, T., Hijioka, T., Kasahara, A., Tajiri, M., Wada, Y., Taniguchi, N., and Miyoshi, E. (2008) Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers. Int J Cancer 122, 2301-2309. 41. Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W., Menon, R., Hermjakob, H., Apweiler, R., Haab, B. B., Simpson, R. J., Eddes, J. S., Kapp, E. A., Moritz, R. L., Chan, D. W., Rai, A. J., Admon, A., Aebersold, R., Eng, J., Hancock, W. S., Hefta, S. A., Meyer, H., Paik, Y. K., Yoo, J. S., Ping, P., Pounds, J., Adkins, J., Qian, X., Wang, R., Wasinger, V., Wu, C. Y., Zhao, X., Zeng, R., Archakov, A., Tsugita, A., Beer, I., Pandey, A., Pisano, M., Andrews, P., Tammen, H., Speicher, D. W., and Hanash, S. M. (2005) Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5, 3226-3245. 42. Gornik, O., Wagner, J., Pucic, M., Knezevic, A., Redzic, I., and Lauc, G. (2009) Stability of N-glycan profiles in human plasma. Glycobiology 19, 1547-1553. 43. Hongsachart, P., Huang-Liu, R., Sinchaikul, S., Pan, F. M., Phutrakul, S., Chuang, Y. M., Yu, C. J., and Chen, S. T. (2009) Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma. Electrophoresis, 1-15. 44. Yu, S. Y., Wu, S. W., and Khoo, K. H. (2006) Distinctive characteristics of MALDI-Q/TOF and TOF/TOF tandem mass spectrometry for sequencing of permethylated complex type N-glycans. Glycoconj J 23, 355-369. 45. Pabst, M., and Altmann, F. (2011) Glycan analysis by modern instrumental methods. Proteomics 11, 631-643. 46. Guillard, M., Gloerich, J., Wessels, H. J., Morava, E., Wevers, R. A., and Lefeber, D. J. (2009) Automated measurement of permethylated serum N-glycans by MALDI-linear ion trap mass spectrometry. Carbohydr Res 344, 1550-1557. 47. Kang, P., Mechref, Y., Klouckova, I., and Novotny, M. V. (2005) Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun Mass Spectrom 19, 3421-3428. 48. Alley, W. R., Jr., and Novotny, M. V. (2010) Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins. J Proteome Res 9, 3062-3072. 49. Sekiya, S., Wada, Y., and Tanaka, K. (2005) Derivatization for stabilizing sialic acids in MALDI-MS. Anal Chem 77, 4962-4968. 50. He, Z., Aristoteli, L. P., Kritharides, L., and Garner, B. (2006) HPLC analysis of discrete haptoglobin isoform N-linked oligosaccharides following 2D-PAGE isolation. Biochem Biophys Res Commun 343, 496-503. 51. Bewick, V., Cheek, L., and Ball, J. (2004) Statistics review 13: receiver operating characteristic curves. Crit Care 8, 508-512. 52. A. Dell, S. C., P. G. Hitchen, J. Jang-Lee, V. Ledger, S. J. North, P.-C. Pang, S. Parry,, and M. Sutton-Smith, B. T., H. R. Morris, M. Panico, and S. M. Haslam, eds. (2007) Comprehensive Glycoscience Elsevier Ltd. 53. Hanai, N., Shitara, K., and Yoshida, H. (1986) Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung. Cancer Res 46, 4438-4443. 54. Fukushima, K., Hirota, M., Terasaki, P. I., Wakisaka, A., Togashi, H., Chia, D., Suyama, N., Fukushi, Y., Nudelman, E., and Hakomori, S. (1984) Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res 44, 5279-5285. 55. Sarkar, A. K., Fritz, T. A., Taylor, W. H., and Esko, J. D. (1995) Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1-->4GlcNAc beta-O-naphthalenemethanol. Proc Natl Acad Sci U S A 92, 3323-3327. 56. Paulson, J. C., Weinstein, J., Dorland, L., van Halbeek, H., and Vliegenthart, J. F. (1982) Newcastle disease virus contains a linkage-specific glycoprotein sialidase. Application to the localization of sialic acid residues in N-linked oligosaccharides of alpha 1-acid glycoprotein. J Biol Chem 257, 12734-12738. 57. Yamashita, K., Koide, N., Endo, T., Iwaki, Y., and Kobata, A. (1989) Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J Biol Chem 264, 2415-2423. 58. Charlwood, J., Birrell, H., Tolson, D., and Camilleri, P. (1998) Two-dimensional chromatography in the analysis of complex glycans from transferrin. Anal Chem 70, 2530-2535. 59. Kuster, B., and Mann, M. (1999) 18O-labeling of N-glycosylation sites to improve the identification of gel-separated glycoproteins using peptide mass mapping and database searching. Anal Chem 71, 1431-1440. 60. Kramer, F., Torzewski, J., Kamenz, J., Veit, K., Hombach, V., Dedio, J., and Ivashchenko, Y. (2008) Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaB- and C/EBPbeta-dependent autocrine interleukin-6 loop. Mol Immunol 45, 2678-2689. 61. Baumann, H., Jahreis, G. P., and Morella, K. K. (1990) Interaction of cytokine- and glucocorticoid-response elements of acute-phase plasma protein genes. Importance of glucocorticoid receptor level and cell type for regulation of the elements from rat alpha 1-acid glycoprotein and beta-fibrinogen genes. J Biol Chem 265, 22275-22281. 62. Narisada, M., Kawamoto, S., Kuwamoto, K., Moriwaki, K., Nakagawa, T., Matsumoto, H., Asahi, M., Koyama, N., and Miyoshi, E. (2008) Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells. Biochem Biophys Res Commun 377, 792-796. 63. Bihl, M., Tamm, M., Nauck, M., Wieland, H., Perruchoud, A. P., and Roth, M. (1998) Proliferation of human non-small-cell lung cancer cell lines: role of interleukin-6. Am J Respir Cell Mol Biol 19, 606-612. 64. Yamaji, H., Iizasa, T., Koh, E., Suzuki, M., Otsuji, M., Chang, H., Motohashi, S., Yokoi, S., Hiroshima, K., Tagawa, M., Nakayama, T., and Fujisawa, T. (2004) Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Cancer Immunol Immunother 53, 786-792. 65. Yanagawa, H., Sone, S., Takahashi, Y., Haku, T., Yano, S., Shinohara, T., and Ogura, T. (1995) Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer 71, 1095-1098. 66. Kang, S. M., Sung, H. J., Ahn, J. M., Park, J. Y., Lee, S. Y., Park, C. S., and Cho, J. Y. (2011) The Haptoglobin beta chain as a supportive biomarker for human lung cancers. Mol Biosyst 7, 1167-1175. 67. Buehler, P. W., Abraham, B., Vallelian, F., Linnemayr, C., Pereira, C. P., Cipollo, J. F., Jia, Y., Mikolajczyk, M., Boretti, F. S., Schoedon, G., Alayash, A. I., and Schaer, D. J. (2009) Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 113, 2578-2586. 68. Graversen, J. H., Madsen, M., and Moestrup, S. K. (2002) CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol 34, 309-314. 69. Xie, Y., Li, Y., Zhang, Q., Stiller, M. J., Wang, C. L., and Streilein, J. W. (2000) Haptoglobin is a natural regulator of Langerhans cell function in the skin. J Dermatol Sci 24, 25-37. 70. Kaartinen, V., and Mononen, I. (1988) Hemoglobin binding to deglycosylated haptoglobin. Biochim Biophys Acta 953, 345-352. 71. Faye, A., Ramey, G., Foretz, M., and Vaulont, S. (2007) Haptoglobin is degraded by iron in C57BL/6 mice: a possible link with endoplasmic reticulum stress. Blood Cells Mol Dis 39, 229-237. 72. Spagnuolo, M. S., Cigliano, L., Maresca, B., Pugliese, C. R., and Abrescia, P. (2011) Identification of plasma haptoglobin forms which loosely bind hemoglobin. Biol Chem 392, 371-376. 73. Kumar, D. M., Thota, B., Shinde, S. V., Prasanna, K. V., Hegde, A. S., Arivazhagan, A., Chandramouli, B. A., Santosh, V., and Somasundaram, K. (2010) Proteomic identification of haptoglobin alpha2 as a glioblastoma serum biomarker: implications in cancer cell migration and tumor growth. J Proteome Res 9, 5557-5567. 74. Bamm, V. V., Tsemakhovich, V. A., Shaklai, M., and Shaklai, N. (2004) Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. Biochemistry 43, 3899-3906. 75. Steirer, L. M., Park, E. I., Townsend, R. R., and Baenziger, J. U. (2009) The asialoglycoprotein receptor regulates levels of plasma glycoproteins terminating with sialic acid alpha2,6-galactose. J Biol Chem 284, 3777-3783. 76. Sato, T., Furukawa, K., Autero, M., Gahmberg, C. G., and Kobata, A. (1993) Structural study of the sugar chains of human leukocyte common antigen CD45. Biochemistry 32, 12694-12704. 77. Tang, Z., Varghese, R. S., Bekesova, S., Loffredo, C. A., Hamid, M. A., Kyselova, Z., Mechref, Y., Novotny, M. V., Goldman, R., and Ressom, H. W. (2010) Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J Proteome Res 9, 104-112. 78. Jia, W., Lu, Z., Fu, Y., Wang, H. P., Wang, L. H., Chi, H., Yuan, Z. F., Zheng, Z. B., Song, L. N., Han, H. H., Liang, Y. M., Wang, J. L., Cai, Y., Zhang, Y. K., Deng, Y. L., Ying, W. T., He, S. M., and Qian, X. H. (2009) A strategy for precise and large scale identification of core fucosylated glycoproteins. Mol Cell Proteomics 8, 913-923. 79. Dai, Z., Fan, J., Liu, Y., Zhou, J., Bai, D., Tan, C., Guo, K., Zhang, Y., Zhao, Y., and Yang, P. (2007) Identification and analysis of alpha1,6-fucosylated proteins in human normal liver tissues by a target glycoproteomic approach. Electrophoresis 28, 4382-4391. 80. Ueda, K., Katagiri, T., Shimada, T., Irie, S., Sato, T. A., Nakamura, Y., and Daigo, Y. (2007) Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. J Proteome Res 6, 3475-3483. 81. Asao, T., Yazawa, S., Nagamachi, Y., Abbas, S. A., and Matta, K. L. (1989) Serum alpha(1----3)-L-fucosyltransferase, carcinoembryonic antigen, and sialyl Lewis X-i antigen levels in lung cancer. Cancer 64, 2541-2545. 82. Yazawa, S., Madiyalakan, R., Izawa, H., Asao, T., Furukawa, K., and Matta, K. L. (1988) Cancer-associated elevation of alpha(1----3)-L-fucosyltransferase activity in human serum. Cancer 62, 516-520. 83. Ogawa, J., Inoue, H., and Koide, S. (1996) Expression of alpha-1,3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer. Cancer Res 56, 325-329. 84. Higai, K., Miyazaki, N., Azuma, Y., and Matsumoto, K. (2006) Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene. FEBS Lett 580, 6069-6075. 85. Wang, D., Hincapie, M., Guergova-Kuras, M., Kadas, J., Takacs, L., and Karger, B. L. (2010) Antigen identification and characterization of lung cancer specific monoclonal antibodies produced by mAb proteomics. J Proteome Res 9, 1834-1842. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33484 | - |
| dc.description.abstract | 醣基化是一種常見的蛋白質修飾，並且在目前癌症研究中引起廣泛的興趣。原因是在癌症的進程中，往往會發現有醣基的改變。肺癌是世界上因癌症死亡的主要癌症之一，而且其發現後的5年存活率小於15%。因此在肺癌血清樣品中尋找生物標誌物是相當重要。我們利用蛋白質體學法，如二維電泳，二維差異凝膠電泳等，鑑定出血紅素結合珠蛋白在肺癌血清樣本中表現量異常增高。西方墨點法與AAL凝集素染色也證實表現量與醣基化程度的不同。這些證據證明血紅素結合珠蛋白的岩藻醣基化顯著地在肺癌各亞型血清中增加。此外，質譜也提供血紅素結合珠蛋白岩藻醣基化增加的證據。並且鑑定其N鍵結醣基的結構為三個唾液酸化的三線端醣，其上3臂甘露醣上的乙醯葡萄醣胺帶有1,3連結的岩藻醣。此特殊醣基化形式上面的唾液酸連結更進一步證實為2,6連結，異於一般所見的sialyl Lewis X抗原。這些初步調查結果顯示，血紅素結合珠蛋白的特殊醣基化形式可作為監測肺癌的發展的生物標記。 | zh_TW |
| dc.description.abstract | Glycosylation is a common protein modification that is of interest in current cancer research because altered carbohydrate moieties are often found during cancer progress. Lung cancer is the major cause of cancer death in the world and the survival rate is less than 15%. A search for biomarkers in human lung cancer serum samples using proteomic approaches, e.g., 2-DE and 2-D DIGE, identified haptoglobin as a protein that is expressed more highly in lung cancer serum samples than in normal serum samples. Western blot analysis and AAL lectin staining were used to validate the expression level and the glycan modification of haptoglobin, respectively. The degree of haptoglobin fucosylation was significantly increased in serum samples from subjects with subtypes of lung cancer compared to normal serum samples. In addition, mass spectrometry provided evidence of an increase of haptoglobin fucosylation; the glycan structure was determined to be an α2,6-linked tri-sialylated triantennary glycan containing α1,3-linked fucose attached to the 4-linked position of the 3-arm mannose of N-linked core pentasaccharide, which is different from the common glycoform , sialyl Lewis X. These preliminary findings suggested that the specific glycoform of haptoglobin may be useful as a marker to monitor lung cancer progression. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T04:43:07Z (GMT). No. of bitstreams: 1 ntu-100-F94b46016-1.pdf: 5326935 bytes, checksum: fbc03b448a9b3bb9fde5d1666da04ff3 (MD5) Previous issue date: 2011 | en |
| dc.description.tableofcontents | 致 謝 I
中 文 摘 要 II ABSTRACT III LIST OF FIGURES IX LIST OF TABLES XI 1. Introduction 1 1-1 Lung cancer 1 1-2 Haptoglobin 2 1-3 Glycosylation changes in cancer 4 2. Experimental procedures 6 2-1 Sample collection 6 2-2 2-DE 7 2-3 2-D DIGE 8 2-4 In-gel tryptic digestion 8 2-5 Western blot analysis and lectin staining 9 2-6 Release and permethylation of glycan 10 2-7 MALDI MS and MS/MS analysis 11 2-8 Nanospray-MSn analysis 13 2-9 Neuraminidase assay 13 2-10 Chemical derivative of sialic acid 15 2-11 Sample analysis and data evaluation 15 3. Results 18 3-1 2-DE and 2-D DIGE of human serum samples 18 3-2 Validation of Hp in lung cancer serum by western blot analysis 21 3-3 Evaluation of fucosylation degree in haptoglobin from serum samples 23 3-4 MS analysis of glycan moiety in Hp isoforms 29 3-5 Determination of the fucosylated trisialylated triantennary glycan structure in Hp by MS/MS 33 3-6 Determination of the sialic acid linkage of triantennary glycan structure in Hp 36 3-7 Further confirmation of the sialic acid linkage of triantennary glycan structure in Hp by neuraminidase and chemical derivative method 41 3-8 Identification of the glycosylaion site in Hp by MS/MS 46 4. Discussions 48 4-1 The fucosylation level of Hp is increased and related to the IL-6 level in serum 48 4-2 The possible function of increasing Hp and F-Hp in lung cancer serum 49 4-3 The novel glyco-epitope on Hp in lung cancer serum is disputed against the previous researches 50 4-4 The possible mechanism causes the change of Hp glycosylation 52 5. Conclusion 53 ACKNOWLEDGMENTS 54 SUPPLEMENTAL DATA 55 RESEARCH PUBLICATIONS 65 REFERENCES 67 | |
| dc.language.iso | en | |
| dc.subject | 血紅素結合珠蛋白 | zh_TW |
| dc.subject | 肺癌 | zh_TW |
| dc.subject | 生物標誌 | zh_TW |
| dc.subject | 轉譯後修飾作用 | zh_TW |
| dc.subject | sialyl Lewis X | zh_TW |
| dc.subject | biomarker | en |
| dc.subject | PTM | en |
| dc.subject | Haptoglobin | en |
| dc.subject | lung cancer | en |
| dc.subject | sialyl Lewis X | en |
| dc.title | 利用醣蛋白質學方法在肺癌血清中鑑定
血清結合珠蛋白的特殊醣基化生物標誌 | zh_TW |
| dc.title | Glycoproteomics analysis to identify a specific glyco- biomarker on haptoglobin associated with lung cancer | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 99-2 | |
| dc.description.degree | 博士 | |
| dc.contributor.oralexamcommittee | 邱繼輝,陳玉如,潘台龍,余忠仁 | |
| dc.subject.keyword | 血紅素結合珠蛋白,肺癌,生物標誌,轉譯後修飾作用,sialyl Lewis X, | zh_TW |
| dc.subject.keyword | Haptoglobin,lung cancer,biomarker,PTM,sialyl Lewis X, | en |
| dc.relation.page | 82 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2011-07-27 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 生化科學研究所 | zh_TW |
| 顯示於系所單位： | 生化科學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-100-1.pdf 未授權公開取用 | 5.2 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。